B-cell lymphoma 2 gene P1 promoter (BCL2 P1 promoter) (BCL2 P1 promoter)

The B-cell lymphoma 2 (BCL-2) gene P1 promoter is the major regulatory element controlling the expression of the BCL-2 protein, a critical inhibitor of apoptosis (Dai et al., 2006). Located approximately 1.4 kb upstream of the translation start site, this promoter is characterized by a GC-rich sequence that can fold into G-quadruplex (G4) structures, which serve as a molecular switch for transcription (Sun et al., 2005). In various malignancies, including follicular lymphoma and chronic lymphocytic leukemia, the BCL-2 gene is often overexpressed or translocated, leading to cell survival and drug resistance (Hurley et al., 2006). Targeting the P1 promoter with small-molecule G4 stabilizers aims to suppress BCL-2 transcription at the genomic level, providing an alternative or complementary approach to protein-targeting BH3 mimetics like venetoclax (Brown et al., 2011). These small molecules, such as TMPyP4 and IMC-48, physically obstruct the transcriptional machinery, including RNA polymerase II and transcription factors like Sp1, by stabilizing the G4 motif (Sun et al., 2008). This strategy leverages the unique structural motifs of the promoter to achieve gene-specific silencing in cancer cells, although challenges remain regarding the selectivity of these molecules across different G4-forming sequences in the genome (Ou et al., 2007). Despite these challenges, the BCL-2 P1 promoter remains a high-interest target for developing next-generation precision oncology therapeutics.

Other names

BCL2 P1 promoterBCL-2 promoterBCL2 G-quadruplexBCL2 G4 DNABCL2 Pu39 sequence

Stabilization of G-quadruplex (G4) structures within the P1 promoter region to inhibit transcription factor binding and RNA polymerase progression, thereby reducing BCL-2 mRNA and protein levels (Hurley et al., 2006; Dai et al., 2006).